Ammar Al-Chalabi is a Clinician Scientist at King’s College London, neurologist at King’s College Hospital and Director of the King’s MND Care and Research Centre. His team researches genetics, epidemiology and clinical trials in ALS.
He co-leads the Project MinE international whole genome sequencing consortium having previously led the BRAIN-MEND and STRENGTH consortia on risk and modifying factors in ALS. He sits on the Executive Board of ENCALS where he chairs the Young Investigator Award Committee, chairs the International Symposium on ALS/MND, and is a National Institute for Health Research Senior Investigator.
His work has been recognized by multiple prizes, including the Forbes Norris Award from the International Alliance of ALS/MND Associations, the Healey Center International Prize for Innovation in ALS, the Sheila Essey Award from the American Academy of Neurology, a Gold National Clinical Excellence Award, and the Charcot Young Investigator Award from the MND Association.